Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-03-01 @ 8:59 PM
Study NCT ID:
NCT06588660
Status:
TERMINATED
Last Update Posted:
2025-07-29
First Post:
2024-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Sponsor:
University of Washington
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RG1123948
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |